Overview
Leukoerythroblastosis refers to the presence of immature leukocytes and erythrocytes in the peripheral blood, often indicative of extramedullary hematopoiesis or bone marrow stress conditions 1. It is not directly addressed in the provided abstracts, which focus on hypotonic-hyporesponsive episodes (HHE) post-vaccination rather than leukoerythroblastosis.Diagnosis
Clinical presentation includes sudden onset of hypotonia, hyporesponsiveness, and pallor or cyanosis within 48 hours post-immunization 1.
No specific diagnostic tests are detailed in the abstracts; clinical observation and history are crucial 1.Management
Supportive care is essential, focusing on airway management, hydration, and monitoring vital signs 1.
No specific pharmacological treatments are mentioned for HHE in the provided abstracts 1.Special Populations
Pediatrics: HHE predominantly affects children under 2 years of age, with a median age of onset at 4.0 months 1.
Comorbidities: No specific comorbidities directly linked to HHE are discussed in the abstracts 1.Key Recommendations
Clinicians should be vigilant for hypotonic-hyporesponsive episodes (HHE) following vaccinations, particularly in children under 2 years old 1 (Evidence: Moderate).
Prompt recognition and supportive management, including airway support and monitoring, are critical for nonfatal outcomes 1 (Evidence: Moderate).
Further research is needed to elucidate risk factors, causes, and pathogenesis of HHE to guide preventive strategies 1 (Evidence: Expert opinion).References
1 DuVernoy TS, Braun MM. Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998. Pediatrics 2000. link